Editorials

• Long-term Outcomes Following Left Atrial Appendage Closure: Gaining Perspective on Non-pharmacological Stroke Prevention in Atrial Fibrillation

  Lluis Asmarats, Josep Rodés-Cabau

  Rev Esp Cardiol. 2019;72:440-2

• Causes of Higher In-hospital Mortality Due to ACS in the Canary Islands and Possible Solutions

  Alberto Cordero, Vicente Bertomeu Martínez

  Rev Esp Cardiol. 2019;72:443-4

• PFO and Cryptogenic Stroke: When Should It Be Closed?

  Raouf Madhkour, Bernhard Meier

  Rev Esp Cardiol. 2019;72:369-72

• Percutaneous Recanalization of Coronary Chronic Total Occlusions: The Case for Centralized Care

  Paul Fefer

  Rev Esp Cardiol. 2019;72:365-6

• A Chicken or Egg Dilemma: Patients With Atrial Fibrillation and Poor Prognostic Outcome in Acute Coronary Syndrome

  Victoria Johnson, Joern Schmitt

  Rev Esp Cardiol. 2019;72:367-8

• Alternative Modes of Exercise Training in Heart Failure With Preserved Ejection Fraction: Is It Time to Give Them Serious Consideration?

  Apostolos Karavidas, Dimitrios Farmakis

  Rev Esp Cardiol. 2019;72:279-81

• Advanced Heart Failure in Congenital Heart Disease: Role of Heart Transplant and Ventricular Assist Devices

  Rafael Alonso-Gonzalez

  Rev Esp Cardiol. 2019;72:285-7

• Stent Thrombosis After ACS-PCI: Does Adherence to Antiplatelet Therapy Involve More Than Its Intensity?

  Zuzana Motovska

  Rev Esp Cardiol. 2019;72:282-4

• Acute Heart Failure Risk Stratification in the Emergency Department: Are We There Yet?

  Frances M. Russell, Peter S. Pang

  Rev Esp Cardiol. 2019;72:190-1

• Is There a Gender Gap in Spanish Cardiology?

  Antonia Sambola, Manuel Anguita, Mireia Giné

  Rev Esp Cardiol. 2019;72:195-7

• Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation

  Sabato Sorrentino, Usman Baber, Roxana Mehran

  Rev Esp Cardiol. 2019;72:192-4

• Role of CMR in Prognostic Stratification in Myocardial Infarction

  Arka Das, Sven Plein, Erica Dall’Armellina

  Rev Esp Cardiol. 2019;72:115-9

• Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy

  SEC Working Group for the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy, Expert Reviewers for the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy, SEC Guidelines Committee

  Rev Esp Cardiol. 2019;72:109-14

• Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension

  SEC Working Group for the 2018 ESC ESH Guidelines on Arterial Hypertension, Expert Reviewers for the 2018 ESC ESH Guidelines on Arterial Hypertension, SEC Guidelines Committee

  Rev Esp Cardiol. 2019;72:104-8

• From Prevention to Rehabilitation: Toward a Comprehensive Approach to Tackling Cardiac Arrest

  Violeta González-Salvado, Antonio Rodríguez-Núñez, José Ramón González-Juanatey

  Rev Esp Cardiol. 2019;72:3-6

• Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction

  SEC Working Group for the 2018 ESC Fourth Universal Definition of Myocardial Infarction, Expert Reviewers for the 2018 ESC Fourth Universal Definition of Myocardial Infarction, SEC Guidelines Committee

  Rev Esp Cardiol. 2019;72:10-5

• MicroRNAs and Congenital Heart Disease: Where Are We Now?

  Silvia Pulignani, Maria Grazia Andreassi

  Rev Esp Cardiol. 2019;72:7-9

• Comments on the 2018 ESC/EACTS Guidelines for Myocardial Revascularization

  SEC Working Group for the 2018 ESC/EACTS Guidelines for Myocardial Revascularization, Expert Reviewers for the 2018 ESC/EACTS Guidelines for Myocardial Revascularization, SEC Guidelines Committee

  Rev Esp Cardiol. 2019;72:16-20

• Keys to a Long and Healthy Life

  Ramón Estruch, Emilio Sacanella

  Rev Esp Cardiol. 2018;71:993-5

• Drugs That Improve Cardiovascular Prognosis in Diabetes and Are Not Yet Used by Cardiologists

  Almudena Castro, Domingo Marzal

  Rev Esp Cardiol. 2018;71:999-1000